Antibiotic-resistant pneumococcal disease in South African children.

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1995) 2.50

Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol (1998) 2.24

Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995. CMAJ (1998) 1.78

Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network. Antimicrob Agents Chemother (1996) 1.74

The pneumococcal problem. BMJ (1996) 1.69

Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice. Can Fam Physician (1998) 1.59

Diagnosis and treatment of bacterial meningitis. Arch Dis Child (2003) 1.39

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob Agents Chemother (1994) 1.23

Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries? Arch Dis Child (2003) 1.10

Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc Natl Acad Sci U S A (1995) 1.03

Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population. Bull World Health Organ (1997) 1.03

Epidemiology, control and treatment of multiresistant pneumococci. Drugs (1996) 1.00

Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey. Clin Vaccine Immunol (2013) 0.93

Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada. J Clin Microbiol (2002) 0.90

Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 0.90

Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model. Antimicrob Agents Chemother (2003) 0.90

Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008. Antimicrob Agents Chemother (2012) 0.86

Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone. Antimicrob Agents Chemother (1994) 0.85

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated in Algiers, Algeria. Antimicrob Agents Chemother (2003) 0.83

Clinical effects of gemifloxacin on the delay of tuberculosis treatment. J Korean Med Sci (2013) 0.79

In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1995) 0.78

High prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda: A cross-sectional study. Ups J Med Sci (2015) 0.76

Antibiotic resistant Streptococcus pneumoniae. Thorax (1996) 0.76

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med (1994) 6.92

Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol (2001) 6.66

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis (1999) 3.72

Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet (1992) 3.42

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09

Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa. Antimicrob Agents Chemother (1993) 2.44

Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis (2000) 2.02

Alterations in PBP 1A essential-for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 1.98

Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis (2007) 1.87

Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes. Pediatr Infect Dis J (2000) 1.87

Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob Agents Chemother (1995) 1.82

Spread of the Spanish multi-resistant serotype 23F clone of Streptococcus pneumoniae to Seoul, Korea. Microb Drug Resist (1997) 1.74

Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis (2011) 1.70

Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J (2000) 1.69

Evaluation of the Etest as a means of determining the antibiotic susceptibilities of isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. J Antimicrob Chemother (2000) 1.67

Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 1.66

Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. Antimicrob Agents Chemother (2001) 1.60

Cardiac complications in children with Staphylococcus aureus bacteremia. J Pediatr (1995) 1.56

Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Dis Child (1986) 1.55

Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr (2000) 1.54

Laboratory-based diagnosis of pneumococcal pneumonia: state of the art and unmet needs. Clin Microbiol Infect (2011) 1.54

Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply. Vaccine (1998) 1.51

'Atypical' bacteria are a common cause of community-acquired pneumonia in hospitalised adults. S Afr Med J (1994) 1.46

Three predominant clones identified within penicillin-resistant South African isolates of Streptococcus pneumoniae. Microb Drug Resist (1997) 1.45

Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis (1998) 1.42

In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrob Agents Chemother (1996) 1.42

Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (2001) 1.40

Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. J Infect Dis (2000) 1.33

Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob Agents Chemother (2000) 1.32

Long-term survival of Streptococcus pneumoniae at room temperature on Dorset egg medium. J Clin Microbiol (1998) 1.26

Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy. J Clin Microbiol (1998) 1.26

Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae. Microb Drug Resist (2000) 1.24

Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (1999) 1.24

Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis (1997) 1.23

Carriage of penicillin resistant pneumococci. Arch Dis Child (1986) 1.20

Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants. Antimicrob Agents Chemother (2000) 1.19

"Megaprimer" method of PCR-based mutagenesis: the concentration of megaprimer is a critical factor. Biotechniques (1997) 1.18

Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother (2001) 1.18

Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg Infect Dis (1998) 1.17

Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 1.16

Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. Pediatr Infect Dis J (2000) 1.10

Worldwide increase in pneumococcal antibiotic resistance. Lancet (1989) 1.08

Urinary tract infection with Corynebacterium urealyticum in South Africa. Eur J Clin Microbiol Infect Dis (1993) 1.07

Neonatal typhoid fever. Pediatr Infect Dis J (1994) 1.07

Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrob Chemother (1994) 1.07

Acquisition of chloramphenicol resistance by the linearization and integration of the entire staphylococcal plasmid pC194 into the chromosome of Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.05

Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob Agents Chemother (2006) 1.04

Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization. Vaccine (1999) 1.04

Laboratory surveillance for Haemophilus influenzae type B meningococcal, and pneumococcal disease. Haemophilus Surveillance Working Group. S Afr Med J (1999) 1.03

Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998. Int J Infect Dis (2000) 1.02

Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother (2007) 1.01

Wound colonization by Ewingella americana. J Clin Microbiol (1986) 1.00

Prevalence of serotypes and molecular epidemiology of Streptococcus pneumoniae strains isolated from children in Beijing, China: identification of two novel multiply-resistant clones. Microb Drug Resist (2001) 1.00

Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults. Chest (1999) 1.00

Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial meningitis in South African children. Int J Infect Dis (2001) 1.00

Colony morphology of piliated Neisseria meningitidis. J Exp Med (1989) 0.98

Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. Semin Respir Infect (1999) 0.97

New gene cassettes for trimethoprim resistance, dfr13, and Streptomycin-spectinomycin resistance, aadA4, inserted on a class 1 integron. Antimicrob Agents Chemother (2000) 0.97

Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts? Clin Infect Dis (2004) 0.96

Novel expansions of the gene encoding dihydropteroate synthase in trimethoprim-sulfamethoxazole-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1999) 0.96

Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care. Clin Microbiol Infect (2009) 0.95

A century of pneumococcal vaccination research in humans. Clin Microbiol Infect (2012) 0.95

Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J (1995) 0.95

Emergence of a pneumococcal clone with cephalosporin resistance and penicillin susceptibility. Antimicrob Agents Chemother (2001) 0.94

Prevalence of trimethoprim resistant dihydrofolate reductase genes identified with oligonucleotide probes in plasmids from isolates of commensal faecal flora. J Antimicrob Chemother (1995) 0.94

Fatal infection caused by a multiply resistant type 3 pneumococcus. J Clin Microbiol (1988) 0.94

Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. J Infect (2008) 0.93

New trimethoprim-resistant dihydrofolate reductase cassette, dfrXV, inserted in a class 1 integron. Antimicrob Agents Chemother (1998) 0.90

Pneumococcal and Haemophilus influenzae meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns. Trop Med Int Health (1999) 0.90

Bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med (1988) 0.90

Meningitis and pneumonia due to novel multiply resistant pneumococci. Br Med J (Clin Res Ed) (1986) 0.89

The molecular mechanisms of tetracycline resistance in the pneumococcus. Microb Drug Resist (1998) 0.89

Analysis of penicillin-binding protein lb and 2a genes from Streptococcus pneumoniae. Microb Drug Resist (2000) 0.88

Body mass and sex as determining factors in the development of fever in rats. J Physiol (1980) 0.88

Use of Dorset egg medium for maintenance and transport of Neisseria meningitidis and Haemophilus influenzae type b. J Clin Microbiol (1999) 0.88

Recurrent penicillin-resistant pneumococcal meningitis after chloramphenicol therapy. Pediatr Infect Dis J (1991) 0.87

Application of pbp1A PCR in identification of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol (1999) 0.87

Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg. S Afr Med J (2000) 0.86

Increased resistance to amikacin in a neonatal unit following intensive amikacin usage. Antimicrob Agents Chemother (1992) 0.85

Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. Eur J Clin Microbiol Infect Dis (2014) 0.85

Actinobacillus (Pasteurella) ureae meningitis in a HIV-positive patient. Diagn Microbiol Infect Dis (1994) 0.84

Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother (1997) 0.84

Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J (2001) 0.83

Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas. Eur J Clin Microbiol Infect Dis (1994) 0.83

Prevalence and genetic location of non-transferable trimethoprim resistant dihydrofolate reductase genes in South African commensal faecal isolates. Epidemiol Infect (1995) 0.83

The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal. Eur Respir J (2010) 0.82

Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus. J Infect (1987) 0.82

Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy. Eur J Clin Microbiol Infect Dis (2005) 0.82

Severe lower respiratory tract infections associated with human parainfluenza viruses 1-3 in children infected and noninfected with HIV type 1. Eur J Clin Microbiol Infect Dis (2002) 0.82

Antibiotic resistance in pneumococcal meningitis. Lancet (1992) 0.81

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC. J Chemother (2004) 0.80

Incidence of high-level gentamicin resistance in enterococci at Johannesburg Hospital. S Afr Med J (1996) 0.80

Impact of antimicrobial resistance and antibiotic choice on the outcome of pneumococcal meningitis. S Afr Med J (1997) 0.80

Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother (2007) 0.80

Mutations within the rplD Gene of Linezolid-Nonsusceptible Streptococcus pneumoniae Strains Isolated in the United States. Antimicrob Agents Chemother (2014) 0.80

Activity of teicoplanin and vancomycin against penicillin-resistant pneumococci. Eur J Clin Microbiol Infect Dis (1994) 0.79

In-vitro activity of cefepime against bacterial pathogens from hospitalized patients. J Antimicrob Chemother (1993) 0.79